Abstract:Abstract Type III CRISPR-Cas systems provide a sequence-specific adaptive immune response that protects prokaryotic hosts against viruses and other foreign genetic invaders. These crRNA-guided Cas effector complexes bind and cleave complementary RNA targets. Specific target binding stimulates the Cas10 subunit to generate cyclic oligoadenylate (cOA) signaling molecules, that in turn allosterically activate proteins carrying cognate sensory domains: CARF or SAVED. Here, we characterize an elaborate set of genes associated with the type III-B CRISPR-Cas system from Haliangium ochraceum , which includes a signal transduction module of a CBASS defense system with two caspase-like proteases, SAVED-CHAT and PCaspase (Prokaryotic Caspase). We show that binding of a 3-nucleotide cOA (cA 3 ) to the SAVED domain of SAVED-CHAT induces its oligomerization into long filaments that activate the proteolytic activity of the CHAT domain. Surprisingly, we find that activated SAVED-CHAT specifically cleaves and activates the second protease, PCaspase. In turn, activated PCaspase cleaves a multitude of other proteins, including a putative sigma factor and a PCaspase-inhibitor. We expressed the type III-B system and its associated genes in E. coli and observed a strong abortive phenotype when offering a complementary target RNA, but only in the presence of both SAVED-CHAT and PCaspase. Together, our findings show an intriguing cascade of proteolytic activities (conceptually similar to eukaryotic caspases) in this bacterial immune system that reveals yet another strategy to effectively defend against mobile genetic elements.

A seed motif for target RNA capture enables efficient immune defense by a Type III-B CRISPR-Cas system.

Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas

Target RNA-guided protease activity in type III-E CRISPR–Cas system

Target RNA activates the protease activity of Craspase to confer antiviral defense

An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference.

Cmr3 Regulates the Suppression on Cyclic Oligoadenylate Synthesis by Tag Complementarity in a Type III-B CRISPR-Cas System

RNA activation‐independent DNA targeting of the Type III CRISPR‐Cas system by a Csm complex

A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction

Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system

Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR–Cas system by binding to target RNA and crRNA

Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in Saccharolobus islandicus

Københavns Universitet Cmr 1 enables efficient RNA and DNA interference of a IIIB CRISPR – Cas system by binding to target RNA and crRNA

The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex

Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry

Target Preference of Type III-A CRISPR-Cas Complexes at the Transcription Bubble.

Bioinformatic analysis of type III CRISPR systems reveals key properties and new effector families

Structural and functional insights into the type III-E CRISPR-Cas immunity

RNA targeting and cleavage by the type III-Dv CRISPR effector complex

Structure and function of a bacterial type III-E CRISPR–Cas7-11 complex

Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages